About Tissue Diagnostics
Tissue diagnostics involves the diagnosis of diseases or analysis of the biological causes of the disease by extracting and analyzing a specific tissue. It has a broad range of applications in clinical research, clinical diagnostics, and cell biology. It is considered one of the most accurate techniques for the diagnosis of inflammatory conditions. Medical specialists particularly use tissue diagnostics in the area of molecular biology for cancer screening, therapy selection, diagnosis, and relapse monitoring. It helps in the screening and diagnosis of lymphoma, melanoma, leukemia, and breast, ovarian, cervical, head and neck, pancreatic, non-small cell lung, colorectal, brain, prostate, lung, and endometrial cancers. Pathologists use different technologies such as in situ hybridization (ISH), immunohistochemistry (IHC), special staining, and digital pathology and related methods including core biopsy, fine needle aspiration cytology, and open biopsy to study and diagnose cells.
Technavios analysts forecast the global tissue diagnostics market to grow at a CAGR of 11.59% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global tissue diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of diagnostic devices based on the following techniques:
Advanced staining
Preanalytical and routine staining
Digital pathology
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavios report, Global Tissue Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Abbott Diagnostics
Agilent Technologies (a parent company of Dako)
Danaher (a parent company of Leica Biosystems)
Roche Diagnostics
Other prominent vendors
20/20 GeneSystems
Abcam
AdnaGen
Advanced Cell Diagnostics
Affymetrix
Agendia
AutoGenomics
AVIVA BioSciences
Biocare Medical
Biocartis
Cancer Genetics
ELITechGroup
Enzo Biochem
Epic Sciences
Fluidigm
HORIBA Medical
Janssen Diagnostics
Olympus Diagnostics Systems Group
Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US)
Oxford Gene Technology
PANAGENE
Protea Biosciences Group
Sakura Finetek
Market driver
Implementation by new customers
For a full, detailed list, view our report
Market challenge
Insurance coverage and reimbursement issues
For a full, detailed list, view our report
Market trend
Ready-to-use reagents
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Global cancer statistics
PART 06: Reimbursement and coverage: An overview
Current scenario: Validating diagnostic tests
Reimbursement structure in US
Reimbursement structure in EU
Prevailing issues of reimbursement policies
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by technology
Global tissue diagnostics market by advanced staining
Global tissue diagnostics market by digital pathology
Global tissue diagnostics market by preanalytical and routine staining
PART 09: Market segmentation by product
Global tissue diagnostics market segmentation by consumables
Global tissue diagnostics market segmentation by instruments
PART 10: Market segmentation by disease
Breast cancer
Lung cancer
Colorectal cancer
Lymphoma
Cervical cancer
Prostate cancer
Other diseases
PART 11: Market segmentation by end-user
Hospitals
CROs
Academia and research institutes
PART 12: Geographical segmentation
Tissue diagnostics market in Americas
Tissue diagnostics market in EMEA
Tissue diagnostics market in APAC
PART 13: Market drivers
Prevalence of chronic diseases
Implementation by new consumers
Use of biomarkers for disease diagnosis
Demand for personalized medicine
PART 14: Impact of drivers
PART 15: Market challenges
Insurance coverage and reimbursement issues
Limitations of closed systems
High initial investment and maintenance costs
PART 16: Impact of drivers and challenges
PART 17: Market trends
Ready-to-use reagents
Focus on system automation
Increase in M&A
PART 18: Vendor landscape
Competitive scenario
Market share analysis 2015
PART 19: Appendix
List of abbreviations
PART 20: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Prevalent cancer types worldwide 2012
Exhibit 03: Countries with highest cancer rate 2012
Exhibit 04: Cancer statistics by gender 2012
Exhibit 05: Reimbursement perspectives of healthcare entities
Exhibit 06: Global tissue diagnostics market 2015-2020 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Global tissue diagnostics market segmentation by technology
Exhibit 09: Global tissue diagnostics market segmentation by technology 2015
Exhibit 10: Global tissue diagnostics market segmentation by technology 2020
Exhibit 11: Global tissue diagnostics market segmentation by technology 2015-2020
Exhibit 12: Global tissue diagnostics market segmentation by advanced staining 2015
Exhibit 13: Global tissue diagnostics market segmentation by advanced staining 2020
Exhibit 14: Global tissue diagnostics market segmentation by advanced staining 2015-2020
Exhibit 15: Global tissue diagnostics market by IHC 2015-2020 ($ billions)
Exhibit 16: Global tissue diagnostics market by ISH 2015-2020 ($ millions)
Exhibit 17: Types of ISH
Exhibit 18: Comparative analysis of CISH, FISH, and IHC
Exhibit 19: Global tissue diagnostics market by advanced staining 2015-2020 ($ billions)
Exhibit 20: Geographical segmentation of global tissue diagnostics market by advanced staining 2015
Exhibit 21: Global tissue diagnostics market by digital pathology 2015-2020 ($ billions)
Exhibit 22: Geographical segmentation of global tissue diagnostics market by digital pathology 2015
Exhibit 23: Global tissue diagnostics market segmentation by preanalytical and routine staining 2015
Exhibit 24: Global tissue diagnostics market segmentation by preanalytical and routine staining 2020
Exhibit 25: Global tissue diagnostics market segmentation by preanalytical and routine staining 2015-2020
Exhibit 26: Global tissue diagnostics market by preanalytical staining 2015-2020 ($ millions)
Exhibit 27: Global tissue diagnostics market by H&E staining 2015-2020 ($ millions)
Exhibit 28: Common special stains used for histological studies
Exhibit 29: Global tissue diagnostics market by special staining 2015-2020 ($ millions)
Exhibit 30: Global tissue diagnostics market by preanalytical and routine staining 2015-2020 ($ billions)
Exhibit 31: Geographical segmentation of global tissue diagnostics market by preanalytical and routine staining 2015
Exhibit 32: Global tissue diagnostics market segmentation by product
Exhibit 33: Global tissue diagnostics market segmentation by product 2015
Exhibit 34: Global tissue diagnostics market segmentation by product 2020
Exhibit 35: Global tissue diagnostics market segmentation by product 2015-2020
Exhibit 36: Global tissue diagnostics market by consumables 2015-2020 ($ billions)
Exhibit 37: Global tissue diagnostics market by instruments 2015-2020 ($ billions)
Exhibit 38: Global tissue diagnostics market segmentation by disease
Exhibit 39: Global tissue diagnostics market segmentation by disease type 2015
Exhibit 40: Global tissue diagnostics market segmentation by end-user
Exhibit 41: Global tissue diagnostics market segmentation by end-user 2015
Exhibit 42: Global tissue diagnostics market segmentation by geography 2015
Exhibit 43: Global tissue diagnostics market segmentation by geography 2020
Exhibit 44: Global tissue diagnostics market segmentation by geography 2015-2020
Exhibit 45: Tissue diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 46: Segmentation of tissue diagnostics market in Americas by technology 2015
Exhibit 47: Tissue diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 48: Segmentation of tissue diagnostics market in EMEA by technology 2015
Exhibit 49: Tissue diagnostics market in APAC 2015-2020 ($ millions)
Exhibit 50: Segmentation of tissue diagnostics market in APAC by technology 2015
Exhibit 51: Impact of drivers
Exhibit 52: Impact of drivers and challenges
Exhibit 53: Ranking of top vendors 2015
Exhibit 54: Roche Diagnostics: Key takeaways
Exhibit 55: Agilent Technologies: Key takeaways
Exhibit 56: Danaher: Key takeaways
Exhibit 57: Abbott Diagnostics: Key takeaways
